Friday 6 November 2026 Export IDXX’s income statement to Excel — free account

IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, up 10.4% from fiscal 2024.

Revenue: +9.86%
EPS: +17.3%
Free cash flow: +17.6%
Total debt: −28.6%

Quarter to September 2026, against a year earlier

677.59 6.88 +1.03%

Follow IDXX

Alert me

Market cap: $52.8B
P/E: 44.8×
Fwd P/E: 37.3×
Dividend yield: —
F-score: 8/9
Altman Z: 24.09
Beneish M: −2.50
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

IDEXX Laboratories, Inc. 10-Q filed May 1, 2025

Fiscal Q1 2025 · Period ended Mar 31, 2025 · Filed May 1, 2025 · accepted 4:11 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors

Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed Oct 31, 2024: no comparison — the earlier filing's text is no longer kept

IDEXX Laboratories, Inc. 10-Q filed May 1, 2025

What changed

Stockrow Weekly